Focally Electrically Administered Seizure Therapy (FEAST) and other developments in stimulatory techniques.
|
|
- Marjory Parker
- 6 years ago
- Views:
Transcription
1 Focally Electrically Administered Seizure Therapy (FEAST) and other developments in stimulatory techniques. Mark S. George, MD Distinguished Professor of Psychiatry, Radiology and Neurology Layton McCurdy Endowed Chair Director, Brain Stimulation Laboratory Medical University of South Carolina Staff Physician Ralph H. Johnson VA Medical Center Charleston, SC USA Royal College of Psychiatrists ECT Team Meeting London UK November, 2016 (via skype)
2 Acknowledgments - Foundations - NARSAD, Stanley, Dana, Hope, Tiny Blue Dot NIMH, NINDS, NIDA, NIAAA, NASA, DARPA, DOD, VA Industry grants (last 20 yrs) Brainsway, Cadwell, Cortex, Cyberonics, Dantec, Darpharma, Electrocore, Glaxo Smith Kline, Jazz, MagStim, MECTA, Medtronic, Neostim, Neosync, Neuronetics, Neotonus, St. Jude Medical. Disclosures - No equity in any device or pharma company Speakers fees from industry (none in past 3 years) Past Paid Consultant - GSK, Cyberonics, NeuroPace, Jazz Unpaid Consultant Brainsway, Neuronetics, Neostim, Neosync Paid Consultant Tal Medical Editor-in-Chief, Brain Stimulation, Elsevier
3 The forgotten half of the truth Electricity is the Currency of the Brain All of synaptic pharmacology simply serves to transmit electrical signals to the next neuron The Brain is an Electrochemical Organ
4 Neuroscience Revolution Much of the brain and behavior conforms to circuitbased models, much like those worked out initially in movement disorders. Non-invasive brain stimulation can interact with these pathological circuits as therapy These new non-invasive techniques have unique side effect, onset of action, and durability profiles, suggesting they are different than traditional therapies (medications, talking, rehab)
5 US FDA Approved Main Transcranial Brain Stimulation Techniques ECT - Electroconvulsive Therapy rtms - repeated Transcranial Magnetic Stimulation Depression DBS - Deep Brain Stimulation PD, dystonia, OCD, epilepsy RST - Responsive Stimulation Therapy, epilepsy Epidural Cortical Stimulation VNS - Vagus Nerve Stimulation depression, epilepsy, morbid obesity Not FDA Approved MST - Magnetic Seizure Therapy tdcs - transcranial Direct Current Stimulation TENS - transcutaneous Electrical Nerve Stimulation EPI-fMRI - echoplanar fmri (LFMS) Transcranial alternating current (tacs) Thync Transcranial pulsed ultrasound
6 Themes Substantial Changes in Thinking Since the 1 st Gottingen Conference Overview of new techniques Focus on ECT, TMS in depression What we know What we are investigating Where it is heading
7 Advances in ECT Use differences in electrode placement, pulse width, type of current to improve efficacy, reduce side effects Right Unilateral Ultrabrief Pulse ECT Advance came from studying TMS pulses, chronaxie Now standard of care, similar efficacy, fewer cognitive side effects. SACKEIM, H. A., PRUDIC, J., NOBLER, M. S., FITZSIMONS, L., LISANBY, S. H., PAYNE, N., BERMAN, R. M., BRAKEMEIER, E. L., PERERA, T. & DEVANAND, D. P Effects of Pulse Width and Electrode Placement on the Efficacy and Cognitive Effects of Electroconvulsive Therapy. Brain stimulation, 1,
8 Treatment efficacy appears to correlate with PreFrontal alterations. Rationale for FEAST Amnestic side effects appear to correlate with Fronto-Temporal alterations.
9 Rationale for FEAST More focal forms of ECT appear to have similar efficacy to less focal forms. However have fewer amnestic Side effects.
10 Focal Electrically Administered Seizure Therapy (FEAST)
11 Experimented with: -Current delivery. -Electrode size. -Electrode placement. N=17 age 53±16 Amnestic Outcome: 5.5±6.4 Mins to 4/5 Clinical Outcome: -5/16 Remission -8/16 Response -Mainly a Feasibility and Methods Development Study
12 The depressed brain: major areas of dysfunction Limbic System Frontal Cortex Medial prefrontal Anterior cingulate Dorsolateral prefrontal Orbital frontal Hippocampus Cortico-limbic dysfunction : a hypothetical view Amygdala Hypothalamicpituitary-adrenal (HPA) axis Nucleus accumbens Higgins and George. Chapter 18, Neuroscience for Clinical Psychiatry, 2007
13 Rational For, and Development of FEAST Study Design of Our Completed Trial Results of Our Completed Trial Limitations of Our Completed Trial Current and Future Directions Sahlem et al, J ECT 2016
14 Inclusion Criteria 1:Major Depressive Episode (MDD or BPAD) 2: HRSD 24-Item 21 3: ECT Indicated Exclusion Criteria 1: Primary Psychosis 2: Substance Use Disorder Past 6 Months 3: Neurological Illness 4: Unstable Medical Condition
15 Baseline 1: Enrollment: SCID, ATHF, etc. 2: Baseline HRSD 24, Baseline Cognitive Battery, etc. Primary outcomes: Clinical Efficacy: -HRSD 24 Remission Amnestic Effects: Re-orientation Time *Initially Pts Were unmediated (N=16), then either NTP, or VLF allowed (N=4) Acute Treatment Phase 24 hours following final treatment FEAST 6X ST treatments 3X/week until remission or plateau in response. Option to switch to RUL or FEAST 9X ST if not improved 40% following tx 6 1: HRSD 24 prior to each odd # treatment. 2: Re-orientation time collected following each treatment. Post Treatment HRSD 24, Cognitive Battery, etc.
16 Rationale For, and Development of FEAST Study Design of Our Completed Trial Results of Our Completed Trial Limitations of our Completed Trial Current and Future Directions
17 Participant/Treatment Characteristics:
18 Newest Study Average Time to Reorientation: (Eyes open to 4/5 correct responses Columbia Autobiographical Memory Index-Short Form: Consistency score: 4.4+/-3.0 mins 97.5%+/-4.1% Sahlem et al,. Expanded Safety and Efficacy Data for a New Method of Performing Electroconvulsive Therapy (ECT): Focal Electrically Administered Seizure Therapy (FEAST). Journal of ECT, 2016
19
20
21
22
23 Rationale For, and Development of FEAST Study Design of Our Completed Trial Results of Our Completed Trial Limitations of Our Completed Trial Current and Future Directions
24 Limitations: Open Label Design Using Historical Data to Contextualize Results Potential for Selection Bias (We may have unintentionally selected less severe/higher functioning patients Potential for Expectation Bias (We may have unintentionally rated optimistically)
25 Rationale For, and Development of FEAST Study Design of Our Completed Trial Results of Our Completed Trial Limitations of Our Completed Trial Current and Future Directions
26 Current/Future Directions: 1: Trials with an UBP-RUL comparison arm Baseline 1: Enrollment: SCID, ATHF, etc. 2: Baseline HRSD 24, Baseline Cognitive Battery, etc. 3: Imaging 2: Studies further explorin mechanism of action Acute Treatment Phase 24 hours following final treatment FEAST 6X ST treatments 3X/week until remission or plateau in response. End HRSD 24, Cognitive Battery, etc. End Imaging UBP-RUL 6X ST treatments 3X/week until remission or plateau in response. 3: Further refinement of technique Follow-up Data out to 6-Months
27 FEAST Conclusions Arose out of cross-fertilization of brain stimulation thinking TMS to ECT, refinement of location, charge, pulse width, other parameters Pilot Studies appear promising More focal application of current (FEAST, MST) may continue to improve and refine ECT Same efficacy Fewer side effects Current Gold Standard (RUL UBP) is pretty hard to beat, a high bar
28 How TMS Works George MS. Sci Am. 2003;289:66-73.
29 Ways to use TMS As a neurophysiological research tool to ping the brain and measure response As an interruption tool to temporarily disrupt a brain region (temporary lesion) As a way to measure brain plasticity paired associative stimulation (PAS) As a potential treatment tool, usually with multiple stimuli over several days
30 Why Brain Stimulation and Depression (1993) MDE is a brain state, reset, normal function, no real residue, unlike AD, Schizo, epilepsy Brain imaging studies suggesting role of cortical governance over limbic activity Response to ECT Presence of cortico-thalamic loops, potential for therapeutic intervention (Alexander, Delong and Strick)
31 Summary of TMS Acute Unipolar Depression Trials 3 Large Prospective RCT support TMS for treating acute moderately treatment resistant depression (3-6 weeks) Remission rates from 15%-30% in the double-blind phase, and 30% or more in open-label Safe, tolerable, but inefficient Modest clinical adoption In US all major insurance, VA Most major countries cover, even the UK NHS Durability appears good 90% retention of response at 12 months
32 No Efficacy/Effectiveness Gap 307 real world US patients, on medication, Neuronetics sponsored, 58% response, 37% remission, average 28 sessions (Carpenter et al, 2012) 100 patients, U Penn practice model, 50% response, 25% remission (Connelly et al, 2012)
33 Prefrontal TMS Clinical Use, Depression
34 Themes Substantial Changes in Thinking Since the 1 st Gottingen Conference Overview of new techniques Focus on ECT, TMS in depression What we know What we are investigating Where it is heading
35 Accelerated TMS 14 Treatment Resistant Depressed Patients, on medications Open-Label TMS, 15 sessions over 2 days, 15,000 total pulses 10 Hz, 5 sec, 25 rest, 100% MT Safe, well-tolerated
36 TMS Anti-suicide Study Can you bake the cake faster? Is Off time needed? High dose, 3 day adjunctive TMS study on inpatients admitted for suicidal ideation Randomized, sham-controlled N=45, two sites RAJVAMC, Walter Reed Two years 18,000 stimuli/day, 54,000 total George et al, Brain Stimulation, 2014
37 Active TMS significantly reduced suicidal ideation Beck Suicide Scale Visual Analog Scale I am currently bothered by thoughts of suicide
38 Seok et al, The efficacy and safety of accelerated rtms in MDD. RCT, 10 patients daily prefrontal rtms for 3 weeks (15 sessions) 10 patients, 15 sessions in 3 days At 3 weeks, no difference between the two groups, similar efficacy and side effects More rapid response in the accelerated group Abstract, Brain Stimulation, 2015, presented in Singapore
39 Dosing pattern conclusions - soft There is nothing sacred about one treatment session per weekday. It appears likely that there is a total dose (stimuli) effect, and that novel delivery patterns are possible May fit better with the logistics of patients and clinics The minimum off time, and max per day, have not been fully established.
40 But Depression Often Recurs Harold Sackeim, PhD
41 Relapse Prevention Study 6 Clinical enrolling sites in US Neuronetics Sponsored Active open 6 weeks treatment, medication free 67 enrolled, 49 later randomized after acute response 73% acute response rate ½ were treated one session per month, the other ½ just monitored All retreated if they begin to relapse
42 Once Monthly rtms, medication free, delayed relapse time Shortened number of sessions needed for re-remission Philips et al, Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation DOI: ( /j.brs )
43 Relapse Prevention Summary It is possible to maintain TRD patients off antidepressants using periodic TMS Once a TMS responder, always a TMS responder high rates of re-response (78% reresponse) The one/month schedule may have been underdosed
44 Other active areas of TMS/Depression Investigation Patterned pulses (theta burst) more efficient. Some open label studies showing near equivalence, much fewer pulses and chair time EEG synchronization? Engaging the brain in cognitive therapy during TMS Are we still underdosing (number of pulses)?
45 When to give up and try the next therapy? Early TMS trials were 2,3,4, then 6 weeks in duration. Gradual improvement in remission rates with longer duration ( %) What to do with a TRD patient at the end of 6 weeks and no response? Try a different form of TMS? Non randomized, then post hoc ergo proctor hoc What about just more of the same?
46 61% of Unmedicated Treatment Resistant Depression Patients Who Did Not Respond to Acute TMS Treatment (6 weeks) Responded After Four Weeks of Twice Weekly Blinded Deep TMS in the Brainsway Pivotal Trial Yip, Roth, Zangen, Carpenter, George Under Review
47 Implications if true With herculean amounts of prefrontal TMS on a daily or twice weekly basis (10 weeks), we may be able to get remission rates approaching ECT (60-70% in TRD patients), with fewer side effects, and longer durability. But at what cost? Chair time, personnel, travel time for patient We thus need to understand what we are doing neurobiologically with each trip to the gym, and make TMS more efficient, less expensive
48 Summary We have exciting new refinements of an older technique ECT (RUL UBP, FEAST, MST) Vastly underutilized There is a quiet revolution underway with the other forms of brain stimulation TMS is emerging as a clinically important tool The various brain stimulation methods are not competitive, but rather synergistic and can be used creatively in treatment algorithms A rising tide floats all boats.
49 ECT course the day before See you there!!
50 Consilience Jumping together of knowledge across diverse backgrounds, viewpoints, reinforcing new conclusions Grateful that organizers of 1 st Gottingen conference invited psychiatrists (me especially), and shared their knowledge, expertise and tools It has taken the combined brainpower of many in this room to launch this new revolution in psychiatry This is an exciting time for brain stimulation in psychiatry New, low hanging fruit, of therapies are within grasping range pain, addictions, anxiety disorders, stroke rehab
51 Acknowledgements MUSC Team: Harold Sackeim Mark George Baron Short James Fox Jon Snipes Suzanne Kerns Will Devries Carol Burns Al Lopez UAB Team: Ziad Nahas MECTA Team:
52 Thanks, Questions
Neuromodulation Approaches to Treatment Resistant Depression
1 Alternative Treatments: Neuromodulation Approaches to Treatment Resistant Depression Audrey R. Tyrka, MD, PhD Assistant Professor Brown University Department of Psychiatry Associate Chief, Mood Disorders
More informationTranscranial Magnetic Stimulation for the Treatment of Depression
Transcranial Magnetic Stimulation for the Treatment of Depression Paul E. Holtzheimer, MD Associate Professor Departments of Psychiatry and Surgery Geisel School of Medicine at Dartmouth Dartmouth-Hitchcock
More informationAmerican University of Beirut University of Minnesota present. Depression: A complex landscape
Medial and Lateral Prefrontal Cortex Neuromodulation Therapies in Depression: A Continuum Ziad Nahas, MD, MSCR Professor and Vice Chair for Clinical Affairs Department of Psychiatry; University of Minnesota
More informationBrain Stimulation. Berry S. Anderson, PhD, RN Mary Rosedale, PhD, PMHNP-BC, NEA-BC Theresa Kormos, PMHCNS-BC Cindy Brown, BSN, RN
Brain Stimulation American Psychiatric Nurses Association 24th Annual Conference October 16, 2010 Kentucky International Convention Center Louisville, Kentucky 1 Berry S. Anderson, PhD, RN Mary Rosedale,
More informationTodd Hutton, M.D. Karl Lanocha, M.D Richard Bermudes, M.D. Kimberly Cress, M.D.
Transcranial Magnetic Stimulation: What You Need To Know Todd Hutton, M.D. Karl Lanocha, M.D Richard Bermudes, M.D. Kimberly Cress, M.D. Disclosures Todd Hutton, M.D. Speaker for Neuronetics Board of Directors,
More informationCharles H. Kellner, MD
ECT: Learning From Recent Trials Charles H. Kellner, MD Professor, Department of Psychiatry Icahn School of Medicine at Mount Sinai ISCTM Philadelphia, PA 27 September, 2016 Charles H. Kellner, MD Disclosures
More informationThe New Clinical Science of ECT
The New Clinical Science of ECT C. Edward Coffey, MD Professor of Psychiatry & Behavioral Sciences, and of Neurology Baylor College of Medicine Houston, Texas Fellow and Past President, International Society
More informationInterventions for Relapsing Depression: TMS, ECT, and Ketamine
Interventions for Relapsing Depression: TMS, ECT, and Ketamine MDD top cause of disability; suicide only top-10 cause of death currently increasing. 10-15% lifetime prevalence A third of patients do not
More informationInterventions for Relapsing Depression: TMS, ECT, and Ketamine
Interventions for Relapsing Depression: TMS, ECT, and Ketamine MDD top cause of disability; suicide only top-10 cause of death currently increasing. 10-15% lifetime prevalence A third of patients do not
More informationStatement on Repetitive Transcranial Magnetic Stimulation for Depression. Position statement CERT03/17
Statement on Repetitive Transcranial Magnetic Stimulation for Depression Position statement CERT03/17 Approved by the Royal College of Psychiatrists, Committee on ECT and Related Treatments: February 2017
More informationNeuromodulation in Epilepsy. Frederick Langendorf,, MD Department of Neurology Univ of MN and Hennepin Co Medical Center June 4, 2007
Neuromodulation in Epilepsy Frederick Langendorf,, MD Department of Neurology Univ of MN and Hennepin Co Medical Center June 4, 2007 disclosures No financial conflicts-of of-interest Epilepsy the problem
More informationTherapeutic Neuromodulation: Overview of a Novel Treatment Platform
Therapeutic Neuromodulation: Overview of a Novel Treatment Platform David G. Brock, MD; and Mark A. Demitrack, MD Shutterstock David G. Brock, MD, is Medical Director, Neuronetics, Inc. Mark A. Demitrack,
More informationFrequently Asked Questions FAQS. NeuroStar TMS Therapies
Frequently Asked Questions FAQS NeuroStar TMS Therapies Provided by Dr Terrence A. Boyadjis MD 790 E Market Street Suite 245 West Chester, PA 19382 610.738.9576 FAQS About TMS Therapies Page 1 NeuroStar
More informationNeuromodulation in Dravet Syndrome. Eric BJ Segal, MD Director of Pediatric Epilepsy Northeast Regional Epilepsy Group Hackensack, New Jersey
Neuromodulation in Dravet Syndrome Eric BJ Segal, MD Director of Pediatric Epilepsy Northeast Regional Epilepsy Group Hackensack, New Jersey What is neuromodulation? Seizures are caused by synchronized
More informationModulation of the Neural Circuitry Underlying Obsessive-Compulsive Disorder
BRAIN STIMULATION LABORATORY Modulation of the Neural Circuitry Underlying Obsessive-Compulsive Disorder OCD Awareness Day NOLAN WILLIAMS, M.D. Instructor Department of Psychiatry Stanford University October
More informationBRAIN STIMULATION AN ALTERNATIVE TO DRUG THERAPY IN MATERNAL DEPRESSION?
BRAIN STIMULATION AN ALTERNATIVE TO DRUG THERAPY IN MATERNAL DEPRESSION? Kira Stein, MD Medical Director West Coast Life Center Sherman Oaks, California CA Maternal Mental Health Initiative - 2013 2013
More informationrtms Versus ECT The Future of Neuromodulation & Brain Stimulation Therapies
rtms Versus ECT The Future of Neuromodulation & Brain Stimulation Therapies rtms Treatment Equipment rtms Equipment Positioning of coil ECT & rtms Innovative Treatment Options for Patients Only a fraction
More informationSetting up a TMS Treatment Program
Setting up a TMS Treatment Program Alvaro Pascual-Leone, M.D., Ph.D. Professor in Neurology Harvard Medical School Beth Israel Deaconess Medical Center Daniel Cohen, M.D., M.M.Sc. Instructor in Neurology
More informationTMS: Full Board or Expedited?
TMS: Full Board or Expedited? Transcranial Magnetic Stimulation: - Neurostimulation or neuromodulation technique based on the principle of electro-magnetic induction of an electric field in the brain.
More informationOscar G. Morales. MD Founding Director McLean Hospital TMS
Institute of Medicine of the National Academies Non-Invasive Neuromodulation of the Central Nervous System: A Workshop Washington, DC. March 2 and 3, 2015 Session IV: Reimbursement Oscar G. Morales. MD
More informationTreatment of Depression: A Brief History
2500 82nd Place Urbandale, Ia Treatment of Depression: A Brief History 1960 s to Present Community Based Services SSRI Antidepressants SNRI Antidepressants 1970 s to present 20% of patients do not respond
More informationTherapeutic Uses of Noninvasive Brain Stimulation Current & Developing
Therapeutic Uses of Noninvasive Brain Stimulation Current & Developing Alvaro Pascual-Leone, MD, PhD Berenson-Allen Center for Noninvasive Brain Stimulation Harvard Catalyst Beth Israel Deaconess Medical
More informationSetting up atms Clinic. Daniel Press, M.D. Assistant Professor in Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center
Setting up atms Clinic Daniel Press, M.D. Assistant Professor in Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center Contents Safety and training of personnel Equipment Certification
More informationMain Brain Stimulation Techniques (partial listing) A Review of the Science and Practical Applications of TMS. Impact of Persistent Depression
Main Brain Stimulation Techniques (partial listing) A Review of the Science and Practical Applications of TMS Jon W. Draud, MS, MD Clinical Professor of Psychiatry University of Tennessee College of Medicine
More informationTranscranial Magnetic Stimulation
Transcranial Magnetic Stimulation Date of Origin: 7/24/2018 Last Review Date: 7/24/2018 Effective Date: 08/01/18 Dates Reviewed: 7/24/2018 Developed By: Medical Necessity Criteria Committee I. Description
More informationBrain Stimulation in Psychiatry
Brain Stimulation in Psychiatry ECT, DBS, TMS, and Other Modalities Brain Stimulation in Psychiatry ECT, DBS, TMS, and Professor, Department of Psychiatry, and Chief, Division of Geriatric Psychiatry,
More informationTranscranial Magnetic Stimulation:
Transcranial Magnetic Stimulation: What has experience told us? Jonathan Downar MD PhD FRCPC MRI-Guided rtms Clinic University Health Network www.rtmsclinic.ca Disclosures Research funding: Canadian Institutes
More informationLEASE DO NOT COPY. Setting up atms Clinic
Setting up atms Clinic Daniel Press, M.D. Assistant Professor in Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center Contents Safety and training of personnel Equipment Certification
More informationWhat is Repetitive Transcranial Magnetic Stimulation?
rtms for Refractory Depression: Findings and Future Jonathan Downar, MD PhD Asst Professor, Dept of Psychiatry University of Toronto, Canada Co-Director, rtms Clinic Toronto Western Hospital University
More informationNOW I M A NEUROSTAR. Let Your Best Self Shine
NOW I M A NEUROSTAR. Let Your Best Self Shine It s Time for a New You NeuroStar Advanced Therapy is an in-office treatment that requires no anesthesia or sedation. You are awake and alert during treatment
More information2018 Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, MD Lundbeck, LLC.
Neuromodulation Techniques: State of the Science Philip G. Janicak, MD Adjunct Professor Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine Consultant
More informationRepetitive Transcranial Magnetic Stimulation as a for Treatment of Refractory Depression and other Psychiatric/Neurologic Disorders
Repetitive Transcranial Magnetic Stimulation as a for Treatment of Refractory Depression and other Psychiatric/Neurologic Disorders Policy Number: Original Effective Date: MM.12.015 08/01/2014 Line(s)
More informationPage 1 of 18 Volume 01 Page 1
Response to Vagus Nerve Stimulation (VNS) Therapy Treatment-Resistant Depression (TRD) Indication Not Approvable Letter from the United States Food and Drug Administration (FDA), Dated August 11, 2004
More informationNeuromodulation in Epilepsy. Gregory C. Mathews, M.D., Ph.D.
Neuromodulation in Epilepsy Gregory C. Mathews, M.D., Ph.D. Disclosure There are no disclosures to share with regards to this presentation. Epilepsy Basics What is epilepsy? Partial versus generalized
More informationOriginal Effective Date: 8/28/2013. Subject: Transcranial Magnetic Stimulation for the Treatment of Major Depression
Subject: Transcranial Magnetic Stimulation for the Treatment of Major Depression Guidance Number: MCG-104 Revision Date(s): Original Effective Date: 8/28/2013 Medical Coverage Guidance Approval Date: 8/28/2013
More informationBME 701 Examples of Biomedical Instrumentation. Hubert de Bruin Ph D, P Eng
BME 701 Examples of Biomedical Instrumentation Hubert de Bruin Ph D, P Eng 1 Instrumentation in Cardiology The major cellular components of the heart are: working muscle of the atria & ventricles specialized
More informationTranscranial Direct Current Stimulation (tdcs) A Promising Treatment for Depression?
Transcranial Direct Current Stimulation (tdcs) A Promising Treatment for Depression? transcranial Direct Current Stimulation (tdcs) Alternating current (AC) 1-3 ma, 9V Direct Current (DC) Direct current:
More informationNonpharmacologic Interventions for Treatment-Resistant Depression. Public Meeting December 9, 2011
Nonpharmacologic Interventions for Treatment-Resistant Depression Public Meeting December 9, 2011 New England CEPAC Goal: To improve the application of evidence to guide practice and policy in New England
More informationFDA CLEARS NEUROSTAR TMS THERAPY FOR THE TREATMENT OF DEPRESSION
FOR IMMEDIATE RELEASE FDA CLEARS NEUROSTAR TMS THERAPY FOR THE TREATMENT OF DEPRESSION First and Only Non-systemic and Non-invasive Treatment Cleared for Patients Who Have Not Benefited From Prior Antidepressant
More informationCase 2:15-cv MWF-JPR Document Filed 03/20/17 Page 1 of 36 Page ID #:388 EXHIBIT 1
Case 2:15-cv-07074-MWF-JPR Document 65-10 Filed 03/20/17 Page 1 of 36 Page ID #:388 EXHIBIT 1 Case 2:15-cv-07074-MWF-JPR Document 65-10 Filed 03/20/17 Page 2 of 36 Page ID #:389 Cigna Medical Coverage
More informationRemission From Depression Is Possible
Remission From Depression Is Possible About Depression Over 350 million people worldwide suffer from depression 1 While medications may help manage symptoms of depression, many patients are not satisfied
More informationInterventions. Individualized Neuromodulation for Neurologic and Psychiatric Disease NEURAL INTERFACES. for Therapeutic OCTOBER 3, 2015
NEURAL INTERFACES for Therapeutic Interventions Individualized Neuromodulation for Neurologic and Psychiatric Disease COURSE DIRECTORS Director, UCLA Neurosurgical Movement Disorders Program UCLA Department
More informationTranscranial Magnetic Stimulation: Scientific Underpinnings and Practical Applications
Transcranial Magnetic Stimulation: Scientific Underpinnings and Practical Applications Jon Draud, MS, MD Clinical Professor of Psychiatry University of Tennessee College of Medicine Memphis, Tennessee
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Transcranial Magnetic Stimulation (TMS) Page 1 of 24 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: See also: Transcranial Magnetic Stimulation (TMS) Vagus Nerve
More informationZinging the Blues. By Kathy Svitil
Zinging the Blues By Kathy Svitil By using magnetic or electrical stimulation to alter neural activity in the brain, neuromodulation joins medications and psychotherapy as a third domain for the treatment
More informationRepetitive transcranial magnetic stimulation for depression
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Interventional procedure consultation document Repetitive transcranial magnetic stimulation for depression Depression causes low mood or sadness that can
More informationDisclosures. Objectives. The Neurobiology of Therapeutic Neuromodulation: Implications for Psychiatric Mental Health Nurses
The Neurobiology of Therapeutic Neuromodulation: Implications for Psychiatric Mental Health Nurses American Psychiatric Nurses Association 26 th Annual Conference November 7, 2012 Pittsburgh, Pennsylvania
More informationResolved: Targeted Intermittent Device Delivered Interventions will Ultimately Prove Superior to Maintenance Treatment with Drugs for Brain Disorders
Resolved: Targeted Intermittent Device Delivered Interventions will Ultimately Prove Superior to Maintenance Treatment with Drugs for Brain Disorders Zhi-De Deng, PhD; Research Fellow, NIMH Bill Potter,
More informationTranscranial Magnetic Stimulation and Cranial Electrical Stimulation (CES) as a Treatment of Depression and Other Psychiatric/Neurologic Disorders
Transcranial Magnetic Stimulation and Cranial Electrical Stimulation (CES) as a Treatment of Depression and Other Psychiatric/Neurologic Disorders Policy Number: 2.01.50 Last Review: 10/2017 Origination:
More informationNoninvasive Neuromodulation Current State & Future Directions
Sarah H. Lisanby, MD Director, Translational Research Division Team B Lead BRAIN Initiative Chief, Noninvasive Neuromodulation Unit Noninvasive Neuromodulation Current State & Future Directions Experimental
More informationLONG-TERM EFFICACY OF REPEATED DAILY PREFRONTAL TRANSCRANIAL MAGNETIC STIMULATION (TMS) IN TREATMNT-RESISTANT DEPRESSION
Research Article DEPRESSION AND ANXIETY 29:883 890 (2012) LONG-TERM EFFICACY OF REPEATED DAILY PREFRONTAL TRANSCRANIAL MAGNETIC STIMULATION (TMS) IN TREATMNT-RESISTANT DEPRESSION Antonio Mantovani, M.D.,
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Transcranial Magnetic Stimulation (TMS) Page 1 of 21 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: See also: Transcranial Magnetic Stimulation (TMS) Vagus Nerve
More informationFuture directions and development in ECT technique May Martin Balslev Jørgensen
Future directions and development in ECT technique May 2014 Martin Balslev Jørgensen Research trends Side effects Augmentation Maintenance Other Brain Stimulation approaches Side Effects Dosing strategies
More informationMending the Mind: treatment of the severely mentally ill
Mending the Mind: treatment of the severely mentally ill First, the bad news Mental Illness Prevalence: putting things in perspective --More than 54 million Americans have a mental disorder in any given
More informationLaurence M. Hirshberg, Sufen Chiu, and Jean A. Frazier
EMERGING INTERVENTIONS Foreword Melvin Lewis xi Preface Laurence M. Hirshberg, Sufen Chiu, and Jean A. Frazier xiii Emerging Brain-Based Interventions for Children and Adolescents: Overview and Clinical
More informationClinical Perspective on Conducting TRD Studies. Hans Eriksson, M.D., Ph.D., M.B.A. Chief Medical Specialist, H. Lundbeck A/S Valby, Denmark
Clinical Perspective on Conducting TRD Studies Hans Eriksson, M.D., Ph.D., M.B.A. Chief Medical Specialist, H. Lundbeck A/S Valby, Denmark Overview of Presentation Treatment-Resistant Depression (TRD)
More informationPatient Manual Brainsway Deep Transcranial Magnetic Stimulation (Deep TMS) System for Treatment of Major Depressive Disorder
Dr. Zahida Tayyib www.mvptms.com Patient Manual Brainsway Deep Transcranial Magnetic Stimulation (Deep TMS) System for Treatment of Major Depressive Disorder If you are considering Brainsway Deep treatment
More informationª The Author(s) The Canadian Journal of Psychiatry / La Revue Canadienne de Psychiatrie 1-15
Canadian Psychiatric Association Association des psychiatres du Canada Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive
More informationAPNA 28th Annual Conference Session 1024: October 22, 2014
Therapeutic Neuromodulation: Implications for Psychiatric Mental Health (PMH) Nurses Mary Rosedale PhD, PMHNP BC Donna Ecklesdafer, MSN, BSN, RN Dawn Miller, BSN, RN Julie Ann Mulder MS, BSN, BS, RN BC
More informationTeresa Jacobson Kimberley, PhD, PT
Teresa Jacobson Kimberley, PhD, PT Professor MGH Institute of Health Professions School of Rehabilitation and Health Sciences Department of Physical Therapy tkimberley@mgh.harvard.edu Disclosures Human
More informationTranscranial Magnetic Stimulation (TMS)
Transcranial Magnetic Stimulation (TMS) The treatment coil produces MRI-strength magnetic field pulses. Magnetic field pulses pass unimpeded through the cranium for 2-3 cm. and induce a small electric
More informationThe possibility of deep brain stimulation to treat eating disorders.
The possibility of deep brain stimulation to treat eating disorders. Andres M Lozano MD PhD Professor and Dan Family Chair of Neurosurgery Canada Research Chair in Neuroscience Toronto Western Hospital
More informationBrain Stimulation xxx (2012) 1e10. Contents lists available at SciVerse ScienceDirect. Brain Stimulation. journal homepage:
Brain Stimulation xxx (2012) 1e10 Contents lists available at SciVerse ScienceDirect Brain Stimulation journal homepage: www.brainstimjrnl.com Original Research Vagus nerve stimulation therapy randomized
More information1. Introduction Overview Organization of Executive Summary
Executive Summary and Discussion of the Vagus Nerve Stimulation (VNS) Therapy Depression Indication Clinical Data (Updated to Include Information from Deficiency Letter Response) Prepared By: Richard L.
More informationTranscranial Brain Stimulation for Treatment of Psychiatric Disorders
Transcranial Brain Stimulation for Treatment of Psychiatric Disorders Advances in Biological Psychiatry Vol. 23 Series Editors D. Ebert, Freiburg K.P. Ebmeier, Oxford W.F. Gattaz, São Paulo W.P. Kaschka,
More informationVagus Nerve Stimulation in the Treatment of Treatment Resistant Depression
Vagus Nerve Stimulation in the Treatment of Treatment Resistant Depression Approved Date:_02-12-2009 VAGUS NERVE STIMULATION IN THE TREATMENT OF TREATMENT RESISTANT DEPRESSION A Seminar Paper Research
More informationWhere Neuromodulation and Neuropsychology Meet: Promoting Plasticity for Brain Health
Where Neuromodulation and Neuropsychology Meet: Promoting Plasticity for Brain Health Sarah H. Lisanby, MD Director, NIMH Translational Research Division Chief, Noninvasive Neuromodulation Unit, NIMH Intramural
More informationMotor threshold (MT) information acquired using single
ORIGINAL ARTICLE The Maximum-likelihood Strategy for Determining Transcranial Magnetic Stimulation Motor Threshold, Using Parameter Estimation by Sequential Testing Is Faster Than Conventional Methods
More informationFor many patients with neuropsychiatric illnesses, standard
INVITED REVIEW Multifactorial Determinants of the Neurocognitive Effects of Electroconvulsive Therapy Shawn M. McClintock, MSCS, PhD,* Jimmy Choi, PsyD, Zhi-De Deng, PhD,* Lawrence G. Appelbaum, PhD,*
More informationNon-Invasive Neuromodulation of the Central Nervous System: A Workshop. March 2 and 3, 2015
Non-Invasive Neuromodulation of the Central Nervous System: A Workshop March 2 and 3, 2015 Institute of Medicine 500 Fifth St., NW, Room 100 Washington, DC 20001 Background: Based on advances in biotechnology
More informationThe EVEREST Study Dr. Robert Levy, MD, PhD
The EVEREST Study Safety and Effectiveness of Cortical Stimulation in the Treatment of Upper Extremity Hemiparesis Dr. Robert Levy, MD, PhD Departments of Neurosurgery and Physiology Feinberg School of
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: spinal_cord_stimulation 3/1980 10/2017 10/2018 10/2017 Description of Procedure or Service Spinal cord stimulation
More informationGLOBAL NEUROSTIMULATION MARKET
GLOBAL NEUROSTIMULATION MARKET R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p o r t s A b o u t M a r k e t s a n d
More informationre-emerging role The Recent developments have revived interest in brain stimulation for difficult-to-treat patients
The re-emerging role Recent developments have revived interest in brain stimulation for difficult-to-treat patients GOMAN MEDICAL ILLUSTRATIONS FOR CURRENT PSYCHIATRY of therapeutic Philip G. Janicak,
More informationSupraorbital nerve stimulation Cefaly Device - FDA Approved for migraine prevention (also being investigated as acute therapy)
NEUROSTIMULATION/NEUROMODULATION UPDATE Meyer and Renee Luskin Andrew Charles, M.D. Professor Luskin Chair in Migraine and Headache Studies Director, UCLA Goldberg Migraine Program David Geffen School
More information(U) USSOCOM. (U) Magnetic qeeg guided Resonance Therapy (MeRT)
United States Special Operations Command (U) USSOCOM MeRT Clinical Trial for Treatment of TBI COL Mark Baggett, Ph.D., US Army USSOCOM Command Psychologist Date: 14 Feb 2018 1 (U) Magnetic qeeg guided
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: vagus_nerve_stimulation 6/1998 5/2017 5/2018 5/2017 Description of Procedure or Service Stimulation of the
More informationAPNA 25th Annual Conference October 19, Session 1035
1 Therapeutic Brain Stimulation: Past, Present, Future and Critical Issues for Psychiatric-Mental Health Nurses American Psychiatric Nurses Association 25 th Annual Conference October 19, 2011 Anaheim,
More informationIntroduction to TMS Transcranial Magnetic Stimulation
Introduction to TMS Transcranial Magnetic Stimulation Lisa Koski, PhD, Clin Psy TMS Neurorehabilitation Lab Royal Victoria Hospital 2009-12-14 BIC Seminar, MNI Overview History, basic principles, instrumentation
More informationTherapeutic Brain Stimulation: Past, Present, Future and Critical Issues for Psychiatric-Mental Health Nurses
Therapeutic Brain Stimulation: Past, Present, Future and Critical Issues for Psychiatric-Mental Health Nurses American Psychiatric Nurses Association 25 th Annual Conference October 19, 2011 Anaheim, California
More informationTranscranial magnetic stimulation for the treatment of major depression
Neuropsychiatric Disease and Treatment open access to scientific and medical research Open Access Full Text Article Review Transcranial magnetic stimulation for the treatment of major depression Philip
More informationNeuromodulation: Harnessing Neuroplasticity with Brain Stimulation and Rehabilitation
Neuromodulation: Harnessing Neuroplasticity with Brain Stimulation and Rehabilitation Presenters: Cecília N. Prudente, PT, MS, PhD 1 Bernadette T. Gillick, PT, MS, PhD 1 Colum MacKinnon, PhD 2 Teresa J.Kimberley,
More informationBringing. to patients with depression
Bringing to patients with depression Hope is knowing remission from depression is possible Depression is a serious illness that affects approximately 350 million people worldwide. 1 While medications may
More informationFENS Neuroethics Seminar. The William Safire Seminar on Neuroethics FENS 2012 Barcelona July 15, 2012
FENS Neuroethics Seminar The William Safire Seminar on Neuroethics FENS 2012 Barcelona July 15, 2012 Invading the Brain: What are the Ethical Issues on Invasive Treatments for Brain Disorders? DBS for
More informationThe basics of tdcs: Marom Bikson. The City College of New York of CUNY
The basics of tdcs: Technology and Mechanism Marom Bikson Lucas Parra, Jacek Dmochowski,Asif Rahman, Niranjan Khadka, Mark Jackson, Dennis Truong, Belen Lafon, Gregory Kronberg, Devin Adair, Nigel Gebodh
More informationTranscranial Magnetic Stimulation
Transcranial Magnetic Stimulation Scientific evidence in major depression and schizophrenia C.W. Slotema Parnassia Bavo Group The Hague, the Netherlands Faraday s law (1831) Electrical current magnetic
More informationCOGNITIVE NEUROSCIENCE
HOW TO STUDY MORE EFFECTIVELY (P 187-189) Elaborate Think about the meaning of the information that you are learning Relate to what you already know Associate: link information together Generate and test
More informationTranscranial magnetic stimulation has become an increasingly
Within-Session Mood Changes From TMS in Depressed Patients Tobias Dang, M.D. David H. Avery, M.D. Joan Russo, Ph.D. Transcranial magnetic stimulation has become an increasingly well studied tool in neuropsychiatry.
More informationNew Research on ECT and development of neuromodulation for treatment of depression
New Research on ECT and development of neuromodulation for treatment of depression Kaisa M. Hartikainen Neurologist, Academy Research Fellow, Associate Professor of Experimental Neurology Behavioral Neurology
More informationNeurostimulation for Epilepsy: Do We Know the Best Stimulation Parameters?
Neurostimulation for Epilepsy: Do We Know the Best Stimulation Parameters? Current Literature In Basic Science Effect of Stimulus Parameters in the Treatment of Seizures by Electrical Stimulation in the
More informationNeuromodulation and Non- Pharmacological Approaches
Multimodal approaches to pain management and potential synergies Neuromodulation and Non- Pharmacological Approaches Richard Wilson, MD Director, Division of Neurologic Rehabilitation MetroHealth Rehabilitation
More informationEPILEPSY. New Ideas about an Old Disease. Gregory D. Cascino, MD
EPILEPSY New Ideas about an Old Disease Gregory D. Cascino, MD Disclosure Research-Educational Grants Neuro Pace, Inc. American Epilepsy Society American Academy of Neurology Neurology (Associate Editor)
More informationThe Next Chapter in Brain Stimulation Therapy
The Next Chapter in Brain Stimulation Therapy Outline I. Depression and Treatment Resistant Depression Barriers to Treatment Treatment Options Cost and Impact of Depression II. Electroconvulsive Therapy
More informationBiological treatments: Electroconvulsive Therapy, Transcranial Magnetic Stimulation, Light therapy
Biological treatments: Electroconvulsive Therapy, Transcranial Magnetic Stimulation, Light therapy Basic trainee talk 23 May 2007 ECT When is ECT used. Depression. Severe, melancholic. Resistant to treatment.
More informationThe effectiveness of transcranial direct current stimulation on ambulation in persons with Parkinson s Disease: A Systematic Review
The effectiveness of transcranial direct current stimulation on ambulation in persons with Parkinson s Disease: A Systematic Review Caitlin Liberatore, SPT Melissa McEnroe, SPT Brian Esterle, SPT Lindsay
More informationResearch Perspectives in Clinical Neurophysiology
Research Perspectives in Clinical Neurophysiology A position paper of the EC-IFCN (European Chapter of the International Federation of Clinical Neurophysiology) representing ~ 8000 Clinical Neurophysiologists
More information9/30/2016. Advances in Epilepsy Surgery. Epidemiology. Epidemiology
Advances in Epilepsy Surgery George Jallo, M.D. Director, Institute for Brain Protection Sciences Johns Hopkins All Children s Hospital St Petersburg, Florida Epidemiology WHO lists it as the second most
More informationObjectives. APNA 27th Annual Conference Session 1021: October 9, Brain Stimulation Techniques. Rosedale, Ecklesdafer, Kormos, Freedland, Knapp 1
The Significant Promise of Therapeutic Neuromodulation: Implications for Psychiatric Mental (PMH) Health Nursing Mary Rosedale PhD, PMHNP BC Donna Ecklesdafer, MSN, RN Theresa Kormos, MSN, PMHCNS BC Michelle
More informationPsychopharmacology 1: ECT
Psychopharmacology 1: ECT Paul Glue paul.glue@otago.ac.nz August 2017 How do antidepressants work? Early theories neurotransmitter deficiency - Unable to demonstrate; doesn t account for diversity of antidepressant
More informationCombining tdcs and fmri. OHMB Teaching Course, Hamburg June 8, Andrea Antal
Andrea Antal Department of Clinical Neurophysiology Georg-August University Goettingen Combining tdcs and fmri OHMB Teaching Course, Hamburg June 8, 2014 Classical Biomarkers for measuring human neuroplasticity
More information